BASi

Patrick R. Ayd has been appointed executive director of clinical operations for the BASi (Bioanalytical Systems, Inc.) clinical research unit in Baltimore, Maryland. He will be responsible for all phases of that operation, including the company’s new first-in-man research unit, a newly opened 10-bed facility that allows intensive monitoring of study participants, including cardiac monitoring, blood pressure and O2 with central monitoring and observation using the Philips comprehensive cardiac monitoring system. The new unit adds to the existing capacity at Baltimore which includes two independent clinical units with 96 beds and mixed-gender capabilities.

Before coming to BASi, Mr. Ayd was vice president of operations at SNBL Clinical Pharmacology Center and headed the design and start-up of its 100-bed clinical pharmacology research center in Baltimore. Prior to that, he was senior director and unit head at Parexel-Baltimore, where he started a Phase I/IIa Clinical Pharmacology unit.